搜索临床试验以:ONC-392
总计6679个结果
-
AstraZenecaParexel尚未招聘
-
InnovaGyn, Inc.Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)招聘中
-
Deepa JagadeeshCase Comprehensive Cancer Center主动,不招人
-
Emory UniversityNational Cancer Institute (NCI); Pfizer; National Institutes of Health (NIH)完全的解剖学 IV 期乳腺癌 AJCC v8 | 预后 IV 期乳腺癌 AJCC v8 | 骨转移性恶性肿瘤 | 雌激素受体阳性 | HER2/Neu 阴性 | 孕激素受体阳性 | 转移性乳腺癌美国
-
Respirent Pharmaceuticals Co Ltd.Becro Ltd.完全的
-
Oregon Health and Science UniversityMedical Research Foundation, Oregon完全的
-
dr hab. n. med. Agnieszka WierzbowskaCopernicus Memorial Hospital; Polish Adult Leukemia Group未知
-
Hospital Clinic of Barcelona未知
-
Janssen Research & Development, LLC完全的
-
Fondazione per la Medicina Personalizzata主动,不招人
-
Washington University School of MedicineNational Institute of Allergy and Infectious Diseases (NIAID)完全的
-
Duke UniversityNational Institute on Drug Abuse (NIDA); National Institutes of Health (NIH); University at Buffalo招聘中
-
Galenika AD BeogradMedicinsko društvo za racionalnu terapiju Republike Srbije (MEDRAT)完全的
-
University of British ColumbiaNatural Sciences and Engineering Research Council, Canada; Canadian Academy of Sport and Exercise... 和其他合作者完全的空气污染 | Exercise-induced Bronchoconstriction加拿大
-
Bristol-Myers Squibb完全的丙型肝炎病毒法国, 德国, 大韩民国, 西班牙, 台湾, 美国, 加拿大, 澳大利亚, 俄罗斯联邦, 奥地利, 以色列, 意大利, 荷兰, 阿根廷, 波兰, 英国, 爱尔兰, 新西兰
-
Texas Oncology Cancer Center终止多发性骨髓瘤 | 慢性淋巴细胞白血病 | 骨髓增生异常综合症 | 急性淋巴细胞白血病 | 急性髓性白血病 | 慢性粒细胞白血病 | 再生障碍性贫血 | 非霍奇金淋巴瘤 | 霍奇金病美国
-
Memorial Sloan Kettering Cancer CenterOtsuka America Pharmaceutical; Ludwig Institute for Cancer Research完全的
-
Institute of Tropical Medicine, BelgiumUniversity Hospital Tuebingen; Mbarara University of Science and Technology; Liverpool School... 和其他合作者完全的
-
National Cancer Institute (NCI)招聘中
-
Rigshospitalet, Denmark未知
-
Vanderbilt-Ingram Cancer CenterNational Cancer Institute (NCI)终止
-
Centre Hospitalier Universitaire de BesanconNational Cancer Institute, France完全的
-
University of PittsburghRoche Pharma AG; Aventis Pharmaceuticals终止